JM2 Capital’s Abbott ABT Stock Holding History

JM2 Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,737	Closed	-$218K	–	115
2025 Q4	$218K	Buy	+1,737	New	+$221K	0.18%	103

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JM2 Capital's ABT Position: Q1 2026 in Review

JM2 Capital sold out of Abbott (ABT) in Q1 2026, closing a stake of 1,737 shares — an estimated $218K sold.

JM2 Capital first reported a position in ABT in Q4 2025 and held it in 1 quarter. The position peaked at $218K in Q4 2025. 3,093 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

JM2 Capital reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
JM2 Capital sold 1,737 Abbott shares in Q1 2026, an estimated $218K.
JM2 Capital first reported a position in Abbott in Q4 2025 and held it in 1 quarter.
JM2 Capital's Abbott position peaked at $218K in Q4 2025.
3,093 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on JM2 Capital's 13F filing for Q1 2026, filed 27 Apr 2026.